Trials / Completed
CompletedNCT04557332
mHealth for ART Adherence by HIV+ African Americans
mHealth for ART Adherence by HIV+ African Americans Age 45 & Older
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 109 (actual)
- Sponsor
- Environment and Health Group, Inc. · Industry
- Sex
- All
- Age
- 30 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this grant is to create and test a mobile app to support ART adherence among HIV+ African American adults.
Detailed description
The Phase II project will enhance the existing (Phase 1) mobile intervention by offering: 1) a two-way communication capability through which participants can: i) indicate "pill taken" in response to pill reminders, and ii) receive a positive visual icon as behavioral-economics based reinforcement for "pill taken" responses; 2) pharmacist counseling and medication support; and, 3) the addition of educational and motivational text messages. Overall aims are to: 1) expand mhealth intervention to incorporate new Phase II features; 2) evaluate effectiveness in an RCT of HIV+ African Americans; and 3) prepare marketing and commercialization plans. Our long-term goal is to increase ART medication adherence, thus decreasing health disparities, among HIV+, African-Americans.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | On the Dot Mobile app | On the Dot is a mobile app to support HIV medication adherence. The mobile app is linked to a clinician portal through which participants can receive adherence support. |
Timeline
- Start date
- 2019-04-01
- Primary completion
- 2020-05-30
- Completion
- 2020-05-30
- First posted
- 2020-09-21
- Last updated
- 2020-09-21
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04557332. Inclusion in this directory is not an endorsement.